No Detail Found!

The role of novel hormone asprosin in insulin resistance during preeclampsia

Author(s)
Nida Shafi Department of Biochemistry, University of Health Sciences,Lahore,Pakistan
Farhat Bano Department of Biochemistry, University of Health Sciences,Lahore,Pakistan
Sammiya Uraneb Department of Biochemistry, University of Health Sciences,Lahore,Pakistan
Abstract
Preeclampsia, a multisystemic syndrome of unknown etiology is characterized by hypertension and proteinuria after 20 weeks of gestation. Metabolic alterations causing insulin resistance and hyperinsulinemia are the prominent factors of preeclampsia. A novel hormone asprosin was discovered to be increased in humans with pathological conditions related to insulin resistance. This study aimed to find relationship between insulin resistance related-hormone asprosin and preeclampsia. A comparative cross-sectional study was conducted on 21 preeclamptic pregnant mothers and 21 healthy pregnant mothers. Samples were taken from mothers at the time of delivery and were processed for estimation of asprosin, insulin and glucose hormones. Data was analysed using SPSS 21. Normality of the data was checked and Independent t-test was applied. A p-value of =0.05 was considered significant. Levels of asprosin, insulin, glucose and HOMA-IR index were significantly elevated in preeclamptic pregnant mothers when compared with healthy pregnant mothers with p-values 0.000, 0.003, 0.036 and 0.002 respectively, suggesting potential role of asprosin in insulin resistance during preeclampsia.
Publication Details
Page(s) 1039-1043
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP3, Year: 2021

Request the full text from PASTIC

Keywords
Preeclampsia, Insulin resistance, Insulin, HOMA-IR, Asprosin
References
Akdemir E,Sahin E,Madendag Y,Sahin ME,Madendag IC,Acmaz G,Ozdemir F,Muhtaroglu S,Muderris II .2020 .Effect of preeclampsia and preeclampsia severity on insulin homa-ir and betatrophin levels in non-diabetic pregnant women. Placenta, 100 : 54-59.
Anim-Nyame N,Ghosh A,Freestone N,Arrigoni FI .2015 .Relationship between insulin resistance and circulating endothelial cells in pre-eclampsia. Gynecol. Endocrinol., 31(10) : 788-791.
Banerjee RR .2018 .Piecing together the puzzle of pancreatic islet adaptation in pregnancy. , 1411(1) : 120-139.
Baykus Y,Yavuzkir S,Ustebay S,Ugur K,Deniz R,Aydin S R .2019 .Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus. Peptides, 120 : 170132.
Coelho SC,Berillo O,Caillon A,Ouerd S,FraulobAquino JC,Barhoumi T,Offermanns S,Paradis P,Schiffrin EL .2018 .Three-month endothelial human endothelin-1 overexpression causes blood pressure elevation and vascular and kidney injury. Hypertension, 71(1) : 208-216.
Ghosh A,Freestone NS,Anim‐Nyame N,Arrigoni FI .2017 .Microvascular function in pre‐eclampsia is influenced by insulin resistance and an imbalance of angiogenic mediators. Physiol. Rep, 5(8) : E13185.
Hoffmann JG,Xie W,Chopra AR .2020 .Energy regulation mechanism and therapeutic potential of asprosin. Diabetes, 69(4) : 559-566.
Huda SS,Forrest R,Paterson N,Jordan F,Sattar N,Freeman DJ N .2014 .In preeclampsia, maternal third trimester subcutaneous adipocyte lipolysis is more resistant to suppression by insulin than in healthy pregnancy. Hypertension, 63(5) : 1094-1101.
Jung TW,Kim HC,Kim HU,Park T,Park J,Kim U,Kim MK,Jeong JH .2019 .Asprosin attenuates insulin signaling pathway through PKCO‐activated ER stress and inflammation in skeletal muscle. J. Cell. Physiol., 234(11) : 20888-20899.
Khaliq OP,Konoshita T,Moodley J,Naicker T .2018 .The role of uric acid in preeclampsia: is uric acid a causative factor or a sign of preeclampsia? Curr. , 20(9) : 80.
Kun A .2011 .Insulin resistance is associated with gestational hypertension and not with preeclampsia: A population-based screening study. Gynecol. Obstet. Invest., 71(4) : 256-261.
Lee T,Yun S,Jeong JH,Jung TW .2019 .Asprosin impairs insulin secretion in response to glucose and viability through Tlr4/Jnk-mediated inflammation. Mol. Cell, 486 : 96-104.
Lopez-Jaramillo P,Barajas J,Rueda-Quijano SM,LopezLopez C,Felix C C .1838 .Obesity and preeclampsia: Common pathophysiological mechanisms. Front. Physiol., 9 : .
Rana S,Lemoine E,Granger JP,Karumanchi S. A. .2019 .Preeclampsia: Pathophysiology, challenges, and perspectives. Circ. Res., 124(7) : 1094-1112.
Romere C,Duerrschmid C,Bournat J,Constable P,Jain M,Xia F,Saha PK,Del Solar M,Zhu B .2016 .Asprosin: A fasting-induced glucogenic protein hormone. Cell, 165(3) : 566-579.
Sáez T,Toledo F,Sobrevia L F .2019 .Extracellular vesicles and insulin resistance: A potential interaction in vascular dysfunction. Curr. Vasc. Pharmacol., 17(5) : 491-497.
Saxena T,Ali AO,Saxena M .2018 .Pathophysiology of essential hypertension: An update. Expert Rev. Cardiovasc. Ther., 16(12) : 879-887.
Sinha S,Singh GP,Gupta K,Kumar S,Gupta A .2014 .Effect of preeclampsia on insulin sensitivity. Int. J. Appl. Basic Med. Res., 4(1) : 7.
Stepan H,Philipp A,Roth I,Kralisch S,Jank A,Schaarschmidt W,Lossner U,Kratzsch J,Bluher M,Stumvoll M M .2012 .Serum levels of the adipokine zinc-α2-glycoprotein are increased in preeclampsia. J. Endocrinol. Investig., 35(6) : 562-565.
Vilela BS,Vasques ACJ,Cassani RSL,Forti ACE,Pareja JC,Tambascia MA,Investigators B,Geloneze B B .2016 .The Homa-adiponectin (Homa-Ad) closely mirrors the Homa-IR index in the screening of insulin resistance in the brazilian metabolic syndrome study (Brams). Plos One, 11(8) : E0158751.
Wang Y,Qu H,Xiong X,Qiu Y,Liao Y,Chen Y,Zheng Y,Zheng H Y .2018 .Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion. Mediators. Inflamm., : 1-7.
Yuan M,Li W,Zhu Y,Yu B,Wu J .2020 .Asprosin: A novel player in metabolic diseases. Front. Endocrinol., 11 : 64.
Zhang X,Jiang H,Ma X,Wu H X .2020 .Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus. J. Diabetes Investig., 11(2) : 349-355.
0

Citations

0

Downloads

10

Views